An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
Weakness
The product transmits or stores authentication credentials, but it uses an insecure method that is susceptible to unauthorized interception and/or retrieval.
Affected Software
| Name | Vendor | Start Version | End Version |
|---|---|---|---|
| Pharmahelp_firmware | Fresenius-kabi | 5.1.759.0 (including) | 5.1.759.0 (including) |
Potential Mitigations
Related Attack Patterns
- https://cwe.mitre.org/data/definitions/102.html
- https://cwe.mitre.org/data/definitions/474.html
- https://cwe.mitre.org/data/definitions/50.html
- https://cwe.mitre.org/data/definitions/509.html
- https://cwe.mitre.org/data/definitions/551.html
- https://cwe.mitre.org/data/definitions/555.html
- https://cwe.mitre.org/data/definitions/560.html
- https://cwe.mitre.org/data/definitions/561.html
- https://cwe.mitre.org/data/definitions/600.html
- https://cwe.mitre.org/data/definitions/644.html
- https://cwe.mitre.org/data/definitions/645.html
- https://cwe.mitre.org/data/definitions/652.html
- https://cwe.mitre.org/data/definitions/653.html
References
- https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder
- https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf
- https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf
- https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder
- https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf
- https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf